Evidence map›Paper›PMID 30241174›Full record

ArticleJournal of global oncology2018

Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia.

Amina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Azra Hasic, Mirza Kozaric, Nermir Granov, Timur Ceric

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amina Kurtovic-KozaricAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Semir VranicAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Sabira KurtovicAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Azra HasicAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Mirza KozaricAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Nermir GranovAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Timur CericAmina Kurtovic-Kozaric, Semir Vranic, Sabira Kurtovic, Mirza Kozaric, Nermir Granov, and Timur Ceric, Clinical Center of the University of Sarajevo; Amina Kurtovic-Kozaric, Semir Vranic, Nermir Granov, Timur Ceric and Azra Hasic, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Molecular Targeted TherapyBosnia and HerzegovinaDeveloping CountriesHealth Services AccessibilityHumansNeoplasmsPrecision MedicineTime-to-Treatment

Identifiers

PMID30241174
PMCPMC6180810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.